PMID 36550723 Syphilitic
PMID 36550723 Syphilitic
PMID 36550723 Syphilitic
net/publication/366201046
CITATIONS READS
0 13
7 authors, including:
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
Significance of COVID vaccines in reducing COVID-19 severity among the infected individuals View project
All content following this page was uploaded by Arun Bahadur Chand on 12 December 2022.
DOI:
ABSTRACT
Background: Venereal syphilis is a sexually transmitted disease, involving pathological activities mediating tissue
destruction by extensive tissue necrosis. As such, the goal amongst researchers has been set to the identification of
effective laboratory biomarkers that can reflect the broad spectrum of disease and ultimately aid in timely diagnosis and
effective treatment of syphilis. This research aimed to study the applications of hematological biomarkers associated
with syphilitic patients visiting a tertiary care hospital.
Methods: A retrospective cross-sectional study was conducted in the syphilitic patients attending KIST Medical
College and Teaching Hospital, Lalitpur, Nepal. A total of 25 syphilitic patients and 41 non-syphilitic participants were
included. The rapid plasma reagin test and Treponema pallidum hemagglutination assay were used for the screening and
confirmation of syphilis respectively. The hematological investigation was performed using a hematology analyzer.
Statistical Package for Social Science version 17.0 was used for data analysis. A P value <0.05 was considered significant.
Results: Syphilitic patients showed significantly elevated levels of lymphocytes (39.8±11.5) (p=0.025), monocyte
(1.9±0.8) (p=0.002), mean corpuscular volume (MCV) (92.6±12.9) (p=0.005), and mean corpuscular hemoglobin
(MCH) (31.9±4.6) (p=0.008) and lowered levels of red blood cell (RBC) (4.2±0.3) (p=0.005) and platelets
(237.2±628.6) (p=0.048) as compared to the lymphocytes (32.9±11.9), monocyte (0.6±1.2), MCV (83.9±8.8),
MCH (34.3±1.5), RBC (4.6±0.7), and platelets (280.9±113.3) of the non-syphilitic participants.
Conclusions: The results showed that the elevated levels of lymphocyte, monocyte, MCV, and MCH and lowered
levels of RBC and platelets are highly specific hematological biomarkers for the diagnosis of patients with syphilis.
Keywords: Hematological biomarkers; sexually transmitted disease; syphilis
Without treatment, the condition can progress This study aimed to provide a comprehensive overview on
understanding the significance of altered hematological records were correctly obtained through communication
biomarkers to improve the diagnosis of syphilitic with involved health-care workers or patients and
patients. patient parties. After complete and detailed information
was obtained, it was recorded in a customized data
METHODS collection form. Statistical analysis was performed by
the SPSS program for Windows, version 17.0. Categorical
This was a hospital-based retrospective study conducted variables were presented as absolute numbers (n)
in the Department of Clinical Laboratory, KIST Medical percentage (%), mean ± Standard Deviation (SD). The
College and Teaching Hospital (KISTMCTH), Lalitpur, independent t-test was used for data analysis. A P-value
Nepal from January 2018 to December 2020. The less than 0.05 was considered as a significant difference.
approval was obtained from the Institutional Review
Committee (IRC) of the KISTMCTH (reference number: RESULTS
2077/078/25). Only syphilitic patients who were
tested using rapid plasma regain (RPR) and Treponema Of the total of 66 patients, 37.8% (n = 25) were syphilitic
pallidum hemagglutination assay (TPHA) techniques patients with the mean age ± Standard deviation of
were included, and individuals without syphilis were 29.1±7.7 years and 62.1% (n = 41) were non-syphilitic
excluded. participants with the mean age of 42.9±24.1. While 52%
(n = 13) patients were male from the syphilitic patients,
A total of 66 patients were recruited for the study. There 53.6% (n = 22) patients were male from the non-syphilitic
were 25 syphilitic patients and 41 healthy individuals, participants (Figure 1).
who were considered as the non-syphilitic participants.
Three milliliter whole blood in EDTA was collected for
hematological testing, while 3 milliliter whole blood
in a gel tube was collected for RPR and TPHA assays.
The flocculation card test was used to detect antibodies
produced against antigens released by damaged host cells
in syphilitic patients. In the test, the serum was mixed
with the RPR antigen. If antibodies were present, they
combined with the lipid particles of the antigen, causing
them to agglutinate with showing up as black clumps
against the white card. A rapid diagnostic test kit, TPHA
was used for the diagnosis of syphilis from each serum
sample. In this test, one drop of serum (25 microliters)
followed by one drop of buffer were added to the sample
port. After 15 minutes, the result was detected. Positive
results were indicated by the appearance of two distinct
pinks to deep purple color bands on the device.
Syphilitic
The hematology analyzer (Sysmax XN-550, Japan) was
Non-syphilitic
used for the testing of complete blood cell count (CBC).
The parameters investigated include white blood cell Figure 1. Showing age groups of syphilis subjects and
(WBC), neutrophil, lymphocyte, monocyte, eosinophil, the non-syphilitic participants.
basophil, red blood cell (RBC), hemoglobin, packed cell
volume (PCV), mean corpuscular volume (MCV), mean Higher incidence of syphilis infection (n =17, 68.0%) was
corpuscular hemoglobin (MCH) and mean corpuscular seen in age group of 20-30 years, whereas age groups
hemoglobin concentration (MCHC) and platelet. of 30-40 years and 50-60 years showed an incidence of
28.0% (n = 7) and 4.0% (n = 1) respectively. The youngest
The relevant demographic data and detailed medical syphilitic patient found to be positive in this study was
history of the syphilitic patients were collected from 21 years and the oldest was 56 years (Figure 1).
the hospital record section. Any missing or ambiguous
Table1. Hematological biomarkers of the syphilitic Moreover, the results showed a moderate decrease
patients and the non-syphilitic participants. in the MCHC (34.2g/l±2.0) (P>0.05) and a moderate
Group increase in hemoglobin (13.7g/dl±2.5) (P>0.05) of the
syphilis subjects as compared to the MCHC (34.3g/l±1.5)
Parameters Non- P-value
Syphilis syphilitic and hemoglobin (13.7g/dl±2.4) of the non-syphilitic
cases participants. Additionally, there was a significant
WBC (X 109 increase in MCV (92.6%±12.9) and MCH (31.9%±4.6) of
13.3±22.0 9.8±5.6 0.340 the syphilis subjects as compared to MCV (83.9%±8.8)
cells/l)
Neutrophil (%) 57.4±12.0 62.2±13.7 0.158 and MCH (28.9% ±3.5) of the non-syphilitic participants
(Table 1).
Lymphocyte
39.8±11.5 32.9±11.9 0.025
(%)
DISCUSSION
Monocyte (%) 1.9± 0.8 0.6±1.2 0.002
Eosinophil (%) 0.7±2.0 2.4±2.4 0.000 Despite the availability of new diagnostic tests and
Basophil (%) 0.0±0.0 0.03± 0.1 0.439 antibiotic therapy, syphilis has re-emerged in several
RBC (X 1012 developed and developing countries, including Nepal.10
4.2± 0.3 4.6± 0.7 0.005
cells/l) Efforts to eliminate syphilis have met with only modest
Hemoglobin success.11 Alternatively, a quantitative measurement
13.7± 2.5 13.7± 2.4 0.996
(g/dl) of disease severity with the use of clinical biomarkers
PCV (%) 39.6±7.1 38.8±6.7 0.674 reflecting pathological development can be of use to
MCV (fl) 92.6±12.9 83.9±8.8 0.005 clinicians for understanding disease prognosis, outcomes,
MCH (pg) 31.9±4.6 28.9±3.5 0.008 and enabling finesse to decision making.12 Therefore, a
study concerning the laboratory biomarkers of a cohort
MCHC (g/l) 34.2±2.0 34.3±1.5 0.767
of 25 patients with syphilis visiting a tertiary care
Platelets (X hospital was conducted. We studied a clear pattern of 13
237.2±628.6 280.9±113.3 0.048
109 cells/l)
hematological biomarkers. To the best of our knowledge,
WBC = White Blood Cell, RBC = Red Blood Cell, PCV = Packed
Cell Volume, MCV = Mean Corpuscular Volume, MCH = Mean this is the first report concerning the significance of
Corpuscular Hemoglobin, MCHC = Mean Corpuscular Hemoglobin hematological biomarkers and their usefulness in the
Concentration. diagnosis of patients with syphilis from Nepal.
The mean values for hematological parameters such and the emergence and rapid spread of macrolide-
as neutrophil (57.4%±12.0), hemoglobin (13.7g/ resistant Treponema pallidum are reminders that there
dl±2.5), PCV (39.6%±7.1), MCV (92.6%±12.9), and MCH is no room for complacency. Lack of ability to study
(31.9%±4.6) from this study were in correspondence with other hematological biomarkers such as cytokines,
the study done by Obeagu et al.,15 which reported the immunoglobulin, and involvement of fewer study
mean values of neutrophil, hemoglobin, PCV, MCV, and subjects were the major limitations of the present study.
MCH as 4.5%±0.6, 14.0g/dl±0.5, 42.0%±3.2, 89.9fl±10,
and 29.9pg±5.6 respectively. Similarly, decreased levels CONCLUSIONS
of hemoglobin (1.9g/dL) and neutrophils (23%) were
also reported by a study by Lee et al. Besides, the mean The result showed that syphilis and the ensuing
values for the parameters such as WBC (13.3X109cells/ immune response can have a tremendous impact on
l±22.0), monocyte (1.9%±0.8), eosinophil (0.7%±2.0), the hematopoietic process and the persistence of
and RBC (4.2X1012cells/L±0.3) from the study were such responses may result in chronic and detrimental
in contrast with the result of the research conducted inflammatory feedback to the hematopoietic system.
by Obeagu et al.,15 which reported the mean values The parameters such as lymphocytes, monocytes,
for WBC, monocyte, eosinophil, basophil, and RBC as eosinophil, RBC, MCH, and platelets are significant
4.5cells/l±0.6X109, 30.6%±7.2%, 1.0%±0.1, 0.1%±0.1, hematological biomarkers for syphilis prognosis and
and RBC 4.7cells/l±0.3 X 1012 respectively. The findings diagnosis as compared to other parameters.
of the study coincide with the report of Hira et al.,18
and Kim et al.,18 which mentioned that almost 90% of CONFLICT OF INTEREST
children with early congenital syphilis diagnosed were
None
anemic. Additionally, the findings from our study were
in contrast to the study of Lee et al.,17 who reported the
REFERENCES
substantially altered value of WBC (53.7K/µL ≈ 0.0537
cell/liter), neutrophils (23%), lymphocytes (65%), and 1. Nyatsanza F, Tipple C. Syphilis: presentations in general
monocytes (7%) in congenital syphilis. Moreover, the medicine. Clinical Medicine. 2016;16(2):184. [PMCID]
mean values of lymphocytes (39.8%±11.5) and platelets
(237.2X109cells/l ± 628.6) from this study also varied 2. Stamm LV. Global challenge of antibiotic-resistant
to the findings of Kim et al.,19 and Obeagu et al.15 Treponemapallidum.Antimicrobial agents and
Conclusively, our study revealed that the hematological chemotherapy. 2010;54(2):583-9.[PMC2812177]
parameters such as lymphocyte, monocyte, eosinophil, 3. GBD 2015 Chronic Respiratory Disease Collaborators.
RBC, MCV, MCH, and platelets showed significant role Global, regional, and nationaldeaths, prevalence,
(P<0.05) in the diagnosis and prognosis of syphilitic disability-adjusted life years, and years lived with disability
patients, which is similar to the conclusion from the for chronic obstructive pulmonary disease and asthma,
study of Obeagu et al.15 1990–2015: a systematic analysis for the Global Burden
of Disease Study 2015. The Lancet. Respiratory Medicine.
Syphilis remains a concerned re-emerged disease 2017;5(9):691.[PMC5573769]
worldwide, as it causes considerable morbidity. The
highly destructive nature of the late stages of syphilis 4. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K,
and the recognition that syphilis infection greatly Aboyans V, et al. Global and regional mortality from 235
increases the transmission and acquisition of HIV, make causes of death for 20 age groups in 1990 and 2010: a
syphilis an important public health concern.7 The risk systematic analysis for the Global Burden of Disease Study
of sexual transmission of syphilis can be reduced by 2010. The lancet. 2012;380(9859):2095-128.[Article]
using a latex condom20,21 Because Treponema pallidum 5. Centers for Disease Control and Prevention (CDC).
shows the presence of several penicillin-binding proteins Resurgent bacterial sexually transmitted disease among
responsible for cell wall synthesis pathways,22 penicillin men who have sex with men-King County, Washington,
kills susceptible bacteria by interfering with the 1997-1999. MMWR. Morbidity and mortality weekly
production of cell walls and remains the drug of choice report. 1999;48(35):773-7.https://www.cdc.gov/
in syphilis treatment. Besides, guidelines published mmwr/preview/mmwrhtml/mm4835a1.htm
by the Centers for Disease Control and Prevention
6. Edward W Hook. Syphilis. The Lancet, 15–21 April 2017.
specify oral doxycycline or tetracycline as alternative
Accessed on 2/24/2021. [Article]
treatments in the case of penicillin allergy (except for
pregnant women).10 The global persistence of syphilis 7. LaFond RE, Lukehart SA. Biological basis for syphilis.
Clinical microbiology reviews. 20061;19(1):29-49. 15. Obeagu EI, Azuonwu O, Didia BC, Obeagu GU,
[PMC1360276] Onyenweaku F. Determination of haematological changes
associated with syphilis in subjects in Umudike, Abia State,
8. Schmid GP, Stoner BP, Hawkes S, Broutet N. The need and
Nigeria. Infect Dis Diag Treat: IDDT-118. Dis. 2018;1:4.
plan for global elimination of congenital syphilis. Sexually
[Download PDF]
transmitted diseases. 2007;34(7):S5-10.[PubMed]
16. Solomon MM, Mayer KH. Evolution of the syphilis
9. Watson-Jones D, Changalucha J, Gumodoka B, Weiss
epidemic among men who have sex with men.Sexual
H, Rusizoka M, Ndeki L, et al. Syphilis in pregnancy in
health. 2015 Apr 1;12(2):96-102.[PMC4470884]
Tanzania. I. Impact of maternal syphilis on outcome
of pregnancy. The Journal of infectious diseases. 17. Lee T, Bell S, Scimeme J, Maraqa N. Congenital
2002;186(7):940-7.[Article] syphilis masquerading as leukemia. AJP reports. 2017
Jul;7(3):e167.[PMC5568859]
10. Centers for Disease Control and Prevention. Sexually
transmitted diseases treatment guidelines 2002.MMWR. 18. Hira SK, Bhat GJ, Patel JB, Din SN, Attili RV, Patel MI, et al.
2002;51(6):32-6. https://www.cdc.gov/mmwr/ Early congenital syphilis: clinico-radiologic features in 202
preview/mmwrhtml/rr5106a1.htm patients. Sexually transmitted diseases. 19851;12(4):177-
83.[Article]
11. Hook III EW, Peeling RW. Syphilis control—a
continuing challenge. New England Journal of Medicine. 19. Kim KY, Kim SH. Hematological aspects of congenital
2004;351(2):122-4.[Article] syphilis. Yonsei medical journal. 1976;17(2):142-50.
[Article]
12. Zhang Y, Li H, Zhang J, Cao Y, Zhao X, Yu N, et al. The
clinical characteristics and outcomes of diabetes mellitus 20. Peeling RW, Mabey D, Kamb ML, Chen XS, Radolf JD,
and secondary hyperglycaemia patients with coronavirus Benzaken AS. Syphilis.Nat Rev Dis Primers. 2017;3:17073.
disease 2019: a single-center, retrospective, observational [Article]
study in Wuhan. Diabetes ObesMetab. 2020:1443–54.
21. Sheet CF. Syphilis & MSM. Atlanta: Centers for Disease
[PMC7273002]
Control and Prevention. 2015. https://www.cdc.gov/
13. CDC NF. The National Center for HIV/AIDS, Viral std/syphilis/stdfact-msm-syphilis.htm
Hepatitis, STD, and TB Prevention.Director.2019 Oct.
22. Radolf JD, Moomaw C, Slaughter CA, Norgard MV.
Accessed on 2/24/2021. https://www.cdc.gov/
Penicillin-binding proteins and peptidoglycan of
nchhstp/default.htm
Treponemapallidum subsp. pallidum.Infection and
14. Harvard Medical School. Sexually transmitted disease? immunity. 1989;57(4):1248-54.[Article]
At my age? Accessed on 2/24/2021. https://www.
health.harvard.edu/diseases-and-conditions/sexually-
transmitted-disease-at-my-age